3x3 or 2x4? [RSABE / ABEL]

posted by Mauricio Sampaio  – Brazil, 2014-10-28 13:12 (3851 d 10:54 ago) – Posting: # 13810
Views: 14,342

Hi Felipe! How are you my friend?

In my opinion, as the my focus is generics drugs products, I suggest the implementation of a reference scaled average bioequivalence using a 4x2 design. Because with test and reference formulations replicated the statistical adjustment is more consistent. Because you have more information from two medicines. In addition, the 4x2 design gives you a real information about your product that can be used in an internal discussion to improve your formulation in case of bioequivalence study fail.

More information read:

Implementation of a Reference Scaled Average Bioequivalence Approach for Highly Variable Generic Drug Products by the US Food and Drug Administration.
The AAPS Journal, Vol.14, No.4, December2012
doi 10.1208/s12248-012-9406-x

Best regards

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
177 visitors (0 registered, 177 guests [including 8 identified bots]).
Forum time: 01:07 CEST (Europe/Vienna)

Only dead fish go with the current.    Scuba divers' proverb

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5